Brinkley Ruth Williams

Insider Reports History

Location
C/O Travere Therapeutics, Inc., 3611 Valley Centre Drive, Suite 300, San Diego, CA
Signature
/s/ Vincent Fontanilla, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brinkley Ruth Williams:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Natera, Inc. Director Common Stock 5.22K $818K $156.66 Jul 25, 2025 Direct
Travere Therapeutics, Inc. Director Common Stock 25.8K $472K $18.33 May 15, 2025 Direct
Travere Therapeutics, Inc. Director Stock option (right to buy) 19.5K May 15, 2025 Direct

Insider Reports Filed by Brinkley Ruth Williams

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NTRA Natera, Inc. Jul 25, 2025 1 $0 4 Jul 29, 2025 Director
NTRA Natera, Inc. Jun 27, 2025 1 $0 4 Jul 1, 2025 Director
TVTX Travere Therapeutics, Inc. May 15, 2025 2 $0 4 May 16, 2025 Director
NTRA Natera, Inc. Jun 28, 2024 1 $0 4 Jul 2, 2024 Director
TVTX Travere Therapeutics, Inc. May 8, 2024 2 $0 4 May 10, 2024 Director
NTRA Natera, Inc. Oct 27, 2023 1 $12.9K 4 Oct 31, 2023 Director
NTRA Natera, Inc. Jul 28, 2023 1 $12.7K 4 Aug 1, 2023 Director
TVTX Travere Therapeutics, Inc. May 17, 2023 2 $0 4 May 19, 2023 Director
NTRA Natera, Inc. Apr 14, 2023 1 $3.95K 4 Apr 18, 2023 Director
NTRA Natera, Inc. Mar 24, 2023 1 $0 4 Mar 28, 2023 Director
NTRA Natera, Inc. Mar 2, 2023 0 $0 3 Mar 10, 2023 Director
TVTX Travere Therapeutics, Inc. May 11, 2022 2 $0 4 May 12, 2022 Director
TVTX Travere Therapeutics, Inc. Sep 14, 2021 2 $0 4 Sep 16, 2021 Director
TVTX Travere Therapeutics, Inc. Sep 14, 2021 0 $0 3 Sep 16, 2021 Director